You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

What is Infanrix-IPV+Hib?

Infanrix-IPV+Hib is a 5-in-1 vaccine that protects against diphtheria, tetanus, whooping cough, polio and Haemophilus influenzae type b (Hib) disease.

It is given as part of the UK Immunisation Schedule to babies at 2, 3 and 4 months of age.[1] There must be at least 4 weeks in between each dose.
Further information about the diseases the vaccine protects against can be found in the links below.

Links and resources

Further information about the 5-in-1 vaccine, diphtheria, tetanus, whooping cough, poliomyelitis and Hib please see:

For further information on Infanrix-IPV+Hib including information on who should not take Infanrix-IPV+Hib and possible side effects, please see the Infanrix-IPV+Hib Patient Information Leaflet (PIL).

If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of this medicine.

Infanrix-IPV+Hib is a registered trademark of the GlaxoSmithKline Group of Companies

L.S. Last updated: 07 December 2015. UK/VAC/0019/14(1)c